Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial (Q34158501)

31 July 2017

Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial (English)

1 reference

31 July 2017

0 references

Jessica R Biesiekierski

1

1 reference

31 July 2017

Evan D Newnham

2

1 reference

31 July 2017

Peter M Irving

3

1 reference

31 July 2017

Jacqueline S Barrett

4

1 reference

31 July 2017

Melissa Haines

5

1 reference

31 July 2017

James D Doecke

6

1 reference

31 July 2017

Susan J Shepherd

7

1 reference

31 July 2017

Jane G Muir

8

1 reference

31 July 2017

Peter R Gibson

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 January 2011

1 reference

The American Journal of Gastroenterology

31 July 2017

1 reference

31 July 2017

106

1 reference

31 July 2017

508-14; quiz 515

1 reference

31 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2010.487

31 July 2017

0 references

cites work

Intestinal antibodies against gliadin, tissue-transglutaminase, beta-lactoglobulin, and ovalbumin in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Intestinal permeability and screening tests for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Gliadin cytotoxicity and in vitro cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Induction of apoptosis in caco-2 cells by wheat gliadin peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Immune dysfunction in patients with functional gastrointestinal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Interactions between commensal bacteria and gut sensorimotor function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

The immunology of gluten sensitivity: beyond the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.487

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.487

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference